Brevan Howard Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$32.2M |
| 2 |
Global X Uranium ETF
URA
|
+$16.9M |
| 3 |
CND.WS
Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CND.WS
|
+$4.73M |
| 4 |
EXE
Expand Energy Corp
EXE
|
+$3.78M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$2.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$15.5M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$13.8M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$9.4M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$5.34M |
| 5 |
CND
Concord Acquisition Corp.
CND
|
+$4.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.77% |
| 2 | Financials | 0.86% |
| 3 | Technology | 0.35% |
| 4 | Real Estate | 0.26% |
| 5 | Energy | 0.19% |
Similar funds
Brevan Howard Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Brevan Howard Capital Management held 63 positions worth $2.43B, up 30% from $1.87B the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Brevan Howard Capital Management deployed $1.32B of net new capital in Q2 2022, opening 29 new positions and adding to 10 existing holdings. Its largest new stake was Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50: 3,580,674 shares worth $3.83M.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.54% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Atomera, an estimated $349K trimmed.
- Brevan Howard Capital Management's largest Q2 2022 buy was Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50: 3,580,674 shares worth $3.83M.
- Brevan Howard Capital Management added most to Moderna in Q2 2022, an estimated $32.2M increase.
- Brevan Howard Capital Management's biggest Q2 2022 reduction was Atomera, cutting an estimated $349K.
- Brevan Howard Capital Management fully exited Baidu in Q2 2022, selling an estimated $15.5M.
- Brevan Howard Capital Management's ten largest holdings make up 91% of its $2.43B portfolio in Q2 2022.
- Brevan Howard Capital Management opened 29 new positions and closed 15 in Q2 2022.
- Brevan Howard Capital Management's portfolio value rose 30% quarter-over-quarter to $2.43B.
Based on Brevan Howard Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.